Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ERAS · against 230 other Healthcare companies of similar size
Ranked #37 of 231 · scores higher than 84% of peers · safety percentile 85
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)19 peers with a safety percentile of 80–89, including ERAS · Click a bar to see the companies
Mainly thanks to its current ratio and debt / equity, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ERAS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 223 reported | 0.12× | 0.24× | 62% | 33% | |
| BetaLower is better · 230 reported | 0.65 | 0.53 | 40% | 33% | |
| Current ratioHigher is better · 223 reported | 8.29× | 2.60× | 83% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 3.6B USD | 99 | ||
| 5 | 3.1B EUR (≈$3.4B) | 99 | 100 | |
| 33 | 6.9B EUR (≈$7.6B) | 87 | ||
| 34 | 3.4B USD | 86 | 35 | |
| 35 | 2.7B USD | 86 | 50 | |
| 36 | 26.9B CNY (≈$3.8B) | 86 | 65 | |
| 37 | 5.1B USD | 85 | 35 | |
| 38 | 6.0B USD | 84 | ||
| 39 | 3.1B USD | 84 | 27 | |
| 40 | 21.6B CNY (≈$3.0B) | 83 | 70 | |
| 41 | 49.0B CNY (≈$6.9B) | 82 | 60 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score